| Literature DB >> 31581881 |
Zengliang Zhang1,2, Nan Li1, Xing Wei3, Bingyao Chen1, Yinglong Zhang1, Yantao Zhao1,4, Xiantong Hu1,4, Shuxun Hou1,5.
Abstract
In recent years, the survey of metabolic glutamate receptor 4 (GRM4) in tumor biology has been gradually concerned. There are currently few studies on GRM4 in osteosarcoma, and the biological function is not clear. Analysis of TCGA database showed that there was no substantial deviation in the expression of GRM4 between osteosarcoma and normal tissues. In the subsequent experiments, there is no significant difference in either mRNA or protein levels among immortalized human osteoblasts and various osteosarcoma cells. With the overexpression of GRM4, cell proliferation, migration and invasion were inhibited obviously. It was further revealed that GRM4 can interact with CBX4 to restrict the nuclear localization of CBX4 and affect the transcriptional activity of HIF-1α. This is the evidence supporting the interaction between GRM4 and CBX4, which could inhibit the malignant behavior of osteosarcoma cells through the GRM4/CBX4/HIF-1α signaling pathway.Entities:
Keywords: CBX4; GRM4; HIF-1α; Osteosarcoma
Mesh:
Substances:
Year: 2019 PMID: 31581881 DOI: 10.1080/09168451.2019.1673147
Source DB: PubMed Journal: Biosci Biotechnol Biochem ISSN: 0916-8451 Impact factor: 2.043